PreludeDx Secures FDA Breakthrough for AidaBREAST Test
LAGUNA HILLS, CALIFORNIA, April 29, 2026 PreludeDx has announced that the U.S. Food and Drug Administration (FDA) has granted...
Oncology
Advertisement
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
Compass Therapeutics Nears Key Data for Tovecimig in BTC
Boston, Massachusetts | April 24, 2026 Compass Therapeutics has announced it will present topline secondary endpoint data from its...
Amphista Targeted Glue Data Shows Tumor Regression
CAMBRIDGE, UK, April 24, 2026 Amphista Therapeutics has unveiled new preclinical data demonstrating the therapeutic potential of its SMARCA2...
Mabwell 9MW2821 Advances to Phase III in TNBC Trial
SHANGHAI, April 23, 2026 Mabwell has announced the initiation of a Phase III clinical trial for its proprietary Nectin-4-targeting...
Advertisements
Telomir Acquires TELI to Secure Global Telomir-1 Rights
MIAMI, FL, April 24, 2026 Telomir Pharmaceuticals has announced the successful completion of its acquisition of TELI Pharmaceuticals, securing...
AbbVie $1.4B Durham Campus to Boost US Drug Manufacturing
NORTH CHICAGO, Ill., April 22, 2026 AbbVie has announced a landmark $1.4 billion investment to establish a state-of-the-art pharmaceutical...
Kyowa Kirin, Kura Oncology Launch Ziftomenib AML Trial
TOKYO & SAN DIEGO, April 24, 2026 Kyowa Kirin and Kura Oncology have announced a major clinical milestone with...
Apotex Expands U.S. Portfolio via Cumberland Deal
TORONTO, April 23, 2026 Apotex Inc. and Cumberland Pharmaceuticals Inc. announced a strategic transaction to integrate Cumberland’s U.S. branded...
PureTech Reports Positive LYT-200 Phase 1b Trial Data
BOSTON, USA, April 22, 2026 PureTech Health plc has announced positive topline results from its Phase 1b clinical trial...
Advertisement
